STOCK TITAN

BioVie holders approve 3.1M-share stock award pool

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

BioVie Inc. (BIVI) reported that stockholders at its November 10, 2026 annual meeting elected all six director nominees—Amy Chappell, Cuong Do, Kameel Farag, James Lang, Sigmund Rogich and Michael Sherman—to serve until the next annual meeting and until their successors are elected and qualified. Stockholders also ratified EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2027.

Stockholders approved an amendment and restatement of the 2019 Omnibus Equity Incentive Plan, increasing shares available for awards from 399,509 to 3,100,000. The amendment received 1,020,704 votes for, 689,489 against and 136,939 abstentions. As of September 21, 2026, 8,682,710 shares of common stock were outstanding; holders of 4,749,367 shares were present virtually or by proxy, constituting a quorum.

Filing Explained

The approved plan raises shares available for future awards from 399,509 to 3,100,000; this filing records expanded capacity, not issuance, so existing holders’ ownership would be diluted if additional shares are issued.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Shares available for awards after plan amendment 3,100,000 shares 2019 Omnibus Equity Incentive Plan
Shares available for awards before plan amendment 399,509 shares 2019 Omnibus Equity Incentive Plan
Votes for plan amendment 1,020,704 votes Annual meeting
Votes against plan amendment 689,489 votes Annual meeting
Abstentions on plan amendment 136,939 votes Annual meeting
Common shares outstanding 8,682,710 shares As of September 21, 2026
Shares represented at annual meeting 4,749,367 shares Present virtually or represented by proxy
quorum regulatory
"constituting a quorum"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
Broker Non-Vote regulatory
"Broker Non-Vote"
A broker non-vote happens when a brokerage firm holds shares in street name for a client but does not cast a ballot on a particular shareholder item because the broker lacks discretionary authority to vote that matter. Think of it like a person who owns a ticket but the ticket-holder refuses to vote on some issues; the share counts for ownership but not for that vote, which can affect whether proposals reach the required number of votes or a quorum.
2019 Omnibus Equity Incentive Plan financial
"amendment and restatement of the 2019 Omnibus Equity Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did BIVI stockholders approve for awards under the 2019 plan?

Stockholders approved increasing the shares available for awards under the 2019 Omnibus Equity Incentive Plan from 399,509 to 3,100,000. The amendment received 1,020,704 votes for, 689,489 against and 136,939 abstentions.

Did BIVI stockholders ratify the auditor?

Yes. Stockholders ratified EisnerAmper LLP as BioVie's independent registered public accounting firm for the fiscal year ending June 30, 2027. The vote was 4,411,653 for, 274,205 against and 63,509 abstentions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001580149 0001580149 2026-11-10 2026-11-10 0001580149 bivi:ClassCommonStockParValue0.0001PerShareMember 2026-11-10 2026-11-10 0001580149 bivi:WarrantsToPurchaseClassCommonStock0.0001ParValuePerShareMember 2026-11-10 2026-11-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 10, 2026

 

BioVie Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   001-39015   46-2510769
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

 

680 W. Nye Lane, Suite 201

Carson City, NV

  89703
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (775) 888-3162

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Class A Common Stock, Par Value $0.0001 Per Share BIVI The Nasdaq Stock Market LLC
Warrants to purchase Class A Common Stock, $0.0001 par value per share BIVIW The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

 

   

 

  

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On November 10, 2026, BioVie Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”). On September 21, 2026, the record date for stockholders entitled to notice of, and to vote at, the Annual Meeting, 8,682,710 shares of the Company’s Class A common stock (“Common Stock”) were outstanding. The holders of 4,749,367 shares of Common Stock were present at the Annual Meeting, either virtually or represented by proxy, constituting a quorum.

 

The following matters were considered at the Annual Meeting and the final voting results are set forth below:

 

Proposal 1. Election of Directors

 

Stockholders elected all of the Company’s nominees for director to hold office until the next annual meeting of stockholders and until their respective successors are elected and qualified. The voting results were as follows:

 

    For     Withhold     Broker Non-Vote  
(1) AMY CHAPPELL   1,732,353     114,779     2,902,235  
(2) CUONG DO   1,719,872     127,260     2,902,235  
(3) KAMEEL FARAG   1,728,973     118,159     2,902,235  
(4) JAMES LANG   1,729,709     117,423     2,902,235  
(5) SIGMUND ROGICH   1,728,685     118,447     2,902,235  
(6) MICHAEL SHERMAN   1,729,940     117,192     2,902,235  

 

Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm

 

Stockholders ratified the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2027. The voting results were as follows:

  

For   Against   Abstain   Broker Non-Vote
4,411,653   274,205   63,509   N/A

 

Proposal 3. Amendment and Restatement of the 2019 Omnibus Equity Incentive Plan

 

Stockholders approved an amendment and restatement of the 2019 Omnibus Equity Incentive Plan to increase the number of shares of Common stock available for issuance pursuant to awards granted thereunder from 399,509 to 3,100,000. The voting results were as follows:

 

For   Against   Abstain   Broker Non-Vote
1,020,704   689,489   136,939   2,902,235

 

   

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BioVie INC.
     
  By: /s/ Joanne Wendy Kim
    Name: Joanne Wendy Kim
    Title: Chief Financial Officer
       
Date: November 10, 2026      

 

   

 

 

Filing Exhibits & Attachments

4 documents

Keep reading